BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30790155)

  • 1. PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis.
    Bingham Iii CO; Gutierrez AK; Butanis A; Bykerk VP; Curtis JR; Leong A; Lyddiatt A; Nowell WB; Orbai AM; Bartlett SJ
    J Patient Rep Outcomes; 2019 Feb; 3(1):14. PubMed ID: 30790155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Minimal and Meaningful Change in a Patient-Reported Outcomes Measurement Information System for Rheumatoid Arthritis: Use of Multiple Methods and Perspectives.
    Bartlett SJ; Gutierrez AK; Andersen KM; Bykerk VP; Curtis JR; Haque UJ; Orbai AM; Jones MR; Bingham CO
    Arthritis Care Res (Hoboken); 2022 Apr; 74(4):588-597. PubMed ID: 33166066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis.
    Bartlett SJ; Gutierrez AK; Butanis A; Bykerk VP; Curtis JR; Ginsberg S; Leong AL; Lyddiatt A; Nowell WB; Orbai AM; Smith KC; Bingham CO
    Qual Life Res; 2018 Sep; 27(9):2443-2451. PubMed ID: 29797175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and Validity of Selected PROMIS Measures in People with Rheumatoid Arthritis.
    Bartlett SJ; Orbai AM; Duncan T; DeLeon E; Ruffing V; Clegg-Smith K; Bingham CO
    PLoS One; 2015; 10(9):e0138543. PubMed ID: 26379233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of the Neurology Quality-of-Life (Neuro-QoL) measurement system in adult epilepsy.
    Victorson D; Cavazos JE; Holmes GL; Reder AT; Wojna V; Nowinski C; Miller D; Buono S; Mueller A; Moy C; Cella D
    Epilepsy Behav; 2014 Feb; 31():77-84. PubMed ID: 24361767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating PROMIS Measures in a Treat-to-Target Approach to Standardize Patient-Centered Treatment of Rheumatoid Arthritis.
    Greene GJ; Beaumont JL; Bacalao EJ; Muftic A; Kaiser K; Eisenstein AR; Mandelin AM; Cella D; Ruderman EM
    J Rheumatol; 2023 Aug; 50(8):1002-1008. PubMed ID: 37127317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and measurement precision of the PROMIS physical function item bank and a content validity-driven 20-item short form in rheumatoid arthritis compared with traditional measures.
    Oude Voshaar MA; Ten Klooster PM; Glas CA; Vonkeman HE; Taal E; Krishnan E; Bernelot Moens HJ; Boers M; Terwee CB; van Riel PL; van de Laar MA
    Rheumatology (Oxford); 2015 Dec; 54(12):2221-9. PubMed ID: 26224306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric Evaluation of the Patient-Reported Outcomes Measurement Information System Fatigue-Short Form Across Diverse Populations.
    Ameringer S; Elswick RK; Menzies V; Robins JL; Starkweather A; Walter J; Gentry AE; Jallo N
    Nurs Res; 2016; 65(4):279-89. PubMed ID: 27362514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Health-Related Quality of Life in Caregivers of Civilians and Service Members/Veterans With Traumatic Brain Injury: Establishing the Reliability and Validity of PROMIS Fatigue and Sleep Disturbance Item Banks.
    Carlozzi NE; Ianni PA; Tulsky DS; Brickell TA; Lange RT; French LM; Cella D; Kallen MA; Miner JA; Kratz AL
    Arch Phys Med Rehabil; 2019 Apr; 100(4S):S102-S109. PubMed ID: 29932884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Patient-Reported Outcomes Measurement Information System Short Forms for Use in Childhood-Onset Systemic Lupus Erythematosus.
    Jones JT; Carle AC; Wootton J; Liberio B; Lee J; Schanberg LE; Ying J; Morgan DeWitt E; Brunner HI
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):133-142. PubMed ID: 27111350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative and psychometric approaches to evaluate the PROMIS pain interference and sleep disturbance item banks for use in patients with rheumatoid arthritis.
    Becker B; Raymond K; Hawkes C; Foster AM; Lovley A; Saucier C; Rizio AA; Bjorner JB; Kosinski M
    J Patient Rep Outcomes; 2021 Jul; 5(1):52. PubMed ID: 34228217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness of Patient-Reported Outcomes Measurement Information System Measures in Rheumatoid Arthritis Patients Starting or Switching a Disease-Modifying Antirheumatic Drug.
    Wohlfahrt A; Bingham CO; Marder W; Phillips K; Bolster MB; Moreland LW; Zhang Z; Neogi T; Lee YC
    Arthritis Care Res (Hoboken); 2019 Apr; 71(4):521-529. PubMed ID: 29885039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study.
    Bingham CO; Black S; Shiff NJ; Xu S; Langholff W; Curtis JR
    Rheumatol Ther; 2023 Jun; 10(3):659-678. PubMed ID: 36820983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).
    IsHak WW; Pan D; Steiner AJ; Feldman E; Mann A; Mirocha J; Danovitch I; Melmed GY
    Inflamm Bowel Dis; 2017 May; 23(5):798-803. PubMed ID: 28301432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities.
    Bacalao EJ; Greene GJ; Beaumont JL; Eisenstein A; Muftic A; Mandelin AM; Cella D; Ruderman EM
    Clin Rheumatol; 2017 Aug; 36(8):1729-1736. PubMed ID: 28653263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of PROMIS measures in clinical studies in patients with inflammatory arthritis: a systematic review.
    Teuwen MMH; Knaapen IRE; Vliet Vlieland TPM; Schoones JW; van den Ende CHM; van Weely SFE; Gademan MGJ
    Qual Life Res; 2023 Oct; 32(10):2731-2749. PubMed ID: 37103773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
    Shaw BE; Syrjala KL; Onstad LE; Chow EJ; Flowers ME; Jim H; Baker KS; Buckley S; Fairclough DL; Horowitz MM; Lee SJ
    Cancer; 2018 Feb; 124(4):841-849. PubMed ID: 29072787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep disturbance in patients with rheumatoid arthritis is related to fatigue, disease activity, and other patient-reported outcomes.
    Austad C; Kvien TK; Olsen IC; Uhlig T
    Scand J Rheumatol; 2017 Mar; 46(2):95-103. PubMed ID: 27319613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS)-57 and -29 item short forms among kidney transplant recipients.
    Tang E; Ekundayo O; Peipert JD; Edwards N; Bansal A; Richardson C; Bartlett SJ; Howell D; Li M; Cella D; Novak M; Mucsi I
    Qual Life Res; 2019 Mar; 28(3):815-827. PubMed ID: 30467780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set.
    Bykerk VP; Bingham CO; Choy EH; Lin D; Alten R; Christensen R; Furst DE; Hewlett S; Leong A; March L; Woodworth T; Boire G; Haraoui B; Hitchon C; Jamal S; Keystone EC; Pope J; Tin D; Thorne JC; Bartlett SJ
    RMD Open; 2016; 2(1):e000225. PubMed ID: 27252895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.